These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 17198350

  • 21. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M, Shomi S, Iwao H, Ochi H.
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [Abstract] [Full Text] [Related]

  • 22. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD.
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [Abstract] [Full Text] [Related]

  • 23. 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.
    Palma E, Correia JD, Oliveira BL, Gano L, Santos IC, Santos I.
    Dalton Trans; 2011 Mar 28; 40(12):2787-96. PubMed ID: 21301703
    [Abstract] [Full Text] [Related]

  • 24. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
    Schümichen C, Koch K, Kraus A, Kuhlicke G, Weiler K, Wenn A, Hoffman G.
    J Nucl Med; 1980 Nov 28; 21(11):1080-5. PubMed ID: 7431108
    [Abstract] [Full Text] [Related]

  • 25. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj, Janković DLj, Stamenković LLj, Pirmettis I.
    Nucl Med Rev Cent East Eur; 2004 Nov 28; 7(1):1-5. PubMed ID: 15318303
    [Abstract] [Full Text] [Related]

  • 26. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A.
    Bioconjug Chem; 2007 Nov 28; 18(6):1924-34. PubMed ID: 17929883
    [Abstract] [Full Text] [Related]

  • 27. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct 28; 21(10):967-70. PubMed ID: 6252299
    [Abstract] [Full Text] [Related]

  • 28. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.
    McKiernan FE, Hocking J, Cournoyer S.
    J Clin Densitom; 2006 Oct 28; 9(2):164-6. PubMed ID: 16785076
    [Abstract] [Full Text] [Related]

  • 29. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE, Blake GM, Fogelman I.
    J Nucl Med; 2008 Mar 28; 49(3):375-82. PubMed ID: 18287266
    [Abstract] [Full Text] [Related]

  • 30. External and biopsy determination of preoperative Tc-99m MDP femoral-head labeling in fracture of the femoral neck: concise communication.
    Strömqvist B, Brismar J, Hansson LI, Thorngren KG.
    J Nucl Med; 1984 Aug 28; 25(8):854-8. PubMed ID: 6235328
    [Abstract] [Full Text] [Related]

  • 31. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb 28; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 32. [99m-Tc alendronate as a new option in bone gammagraphy].
    Montoya-Molina CE, Sepúlveda-Méndez J, Arteaga-de-Murphy C, Meléndez-Alafort L, Rojas-Bautista JC, López-Alvarenga JC.
    Rev Invest Clin; 1997 Feb 28; 49(5):373-7. PubMed ID: 9527697
    [Abstract] [Full Text] [Related]

  • 33. [Regional blood flow and bone uptake of methylene-diphosphonate-technetium-99m].
    Vattimo A, Martini G, Pisani M.
    Boll Soc Ital Biol Sper; 1983 May 30; 59(5):590-5. PubMed ID: 6192828
    [Abstract] [Full Text] [Related]

  • 34. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM.
    J Nucl Med; 1980 Aug 30; 21(8):767-70. PubMed ID: 7400832
    [Abstract] [Full Text] [Related]

  • 35. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
    Ghiron J, Volkert WA, Garlich J, Holmes RA.
    Int J Rad Appl Instrum B; 1991 Aug 30; 18(2):235-40. PubMed ID: 2026500
    [Abstract] [Full Text] [Related]

  • 36. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL, Kiratli PO, Günay EC, Erbaş B.
    Nucl Med Commun; 2006 Nov 30; 27(11):877-85. PubMed ID: 17021428
    [Abstract] [Full Text] [Related]

  • 37. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
    Qiu L, Tang Y, Chen Y, Huang Z, Zhu Y, Zhang L, Cai L, Wan Q, Feng Y.
    Contrast Media Mol Imaging; 2015 Nov 30; 10(6):438-45. PubMed ID: 26036779
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE, Blake GM, Fogelman I.
    J Nucl Med; 2006 Apr 30; 47(4):581-6. PubMed ID: 16595490
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging.
    He Z, Hsieh WY, Kim YS, Liu S.
    Nucl Med Biol; 2006 Nov 30; 33(8):1045-53. PubMed ID: 17127179
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.